The Global Intrauterine Contraceptive Market size is expected to reach USD $1.2 billion by 2028, growing at a CAGR of 5.9% during the forecast period from 2021 to 2028. The key factors driving the growth of this market are rising awareness about unplanned pregnancies and the increasing rate of adoption due to advancements in technology. Rising prevalence rates for infertility are also contributing significantly towards market growth.
Intrauterine Contraceptive (IUDs) are small, contraceptive devices that a doctor inserts into the uterus. They may be referred to as intrauterine contraception or an IUC. Intrauterine Contraceptives (IUCD) is a highly effective form of birth control for women with up to 95% effectiveness in preventing pregnancy and can last between five and twelve years depending on the type. The first IUCD was introduced in the 1970s and has seen major development since then including various shapes, sizes, materials, hormones used, etc. In recent studies, it’s been found that copper-releasing IUDs have very high levels of success when compared to other types which make them popular among doctors around the world.
On the basis of Type, the market is segmented into Hormonal IUCD and Copper IUCD. Copper IUCDs are being used more than hormonal because it has lower side effects such as nausea or acne which are common with women who take estrogen-containing contraceptives.
Hormonal IUCD is a type of intrauterine contraceptive, which prevents pregnancy by releasing hormones into the uterus. Hormonal IUDs are available in different types such as Mirena and Skyla or Liletta and Kyleena. The Hormonal IUDs segment is further bifurcated into Levonorgestrel-releasing Intrauterine System, Depot Medroxyprogesterone Acetate (DMPA)-releasing Intrauterine System and Other.
Copper IUCD is a long-acting, nonhormonal intrauterine device that can be used for birth control. A copper IUD works by releasing small amounts of copper into the uterus which then creates an inflammatory reaction and at the same time releases natural prostaglandin to thicken cervical mucus preventing sperm from fertilizing eggs in parts or fallopian tubes.
The Copper One Intra-Uterine Device (IUCD) has been one of the most popular forms of contraception worldwide since its first introduction in 1988. Its efficacy rates are very high as it provides almost 100% protection against pregnancy while also providing some other benefits such as reduced menstrual cramps, lighter periods, and better general health due to less exposure to hormones.
On the basis of Application, the market is segmented into Hospitals, Gynecological Clinics, Other. There are various types of Intrauterine contraceptives available in hospitals, and they are used for different purposes. The Hospital segment is projected as the largest revenue generator by 2021. Hospitals offer services such as family planning clinics, emergency care centers, or delivery rooms which helps to access IUCDs on time thus having more chances of preventing unwanted pregnancies without any side effects like oral pills.
On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North American market is expected to dominate the global intrauterine contraceptive market. The rise in awareness about contraceptives and their benefits among women is likely to drive this region's growth in the future.
Europe, Asia Pacific, and Middle East & Africa are also estimated to be growing regions for this market due to an increase in the population of females aged between 15-49 years globally where these segments can find a huge potential for increasing demand for IUCDs.
Increasing contraceptive prevalence and population are the prime factors of growth in this market. One of the most important reasons for the use of Intrauterine devices is their efficacy, which can be given from preventing pregnancy with up to 99% effectiveness. In addition, it has fewer side effects as compared to other forms such as oral contraceptives that have a higher risk of getting pregnant again soon after stopping or starting another form.
Up Market Research published a new report titled “Intrauterine Contraceptive Market research report which is segmented by Types (Hormonal IUCD, Copper IUCD), By Applications (Hospitals, Gynecological Clinics, Other), By Players/Companies Teva Pharmaceutical Industries, Medicines360, Trimedic Supply Network, Bayer Healthcare, Actavis, Medisafe Distribution, Pace Pharmaceuticals”.
|Report Attributes||Report Details|
|Report Title||Intrauterine Contraceptive Market Research Report|
|By Type||Hormonal IUCD, Copper IUCD|
|By Application||Hospitals, Gynecological Clinics, Other|
|By Companies||Teva Pharmaceutical Industries, Medicines360, Trimedic Supply Network, Bayer Healthcare, Actavis, Medisafe Distribution, Pace Pharmaceuticals|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||219|
|Number of Tables & Figures||154|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Hormonal IUCD, Copper IUCD and By Application Hospitals, Gynecological Clinics, Other.
Some of the companies that are profiled in this report are:
Intrauterine Contraceptive Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Intrauterine Contraceptive Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Intrauterine Contraceptive Market Report:
Some other reports from this category!